Senior Director, Outcomes, Value & Access

Posted 17 Days Ago
Be an Early Applicant
Watertown, MA, USA
In-Office
235K-330K Annually
Senior level
Healthtech • Biotech • Pharmaceutical
The Role
Lead HEOR, RWE, and value strategy across Kymera's immunology portfolio. Drive economic modeling, payer engagement, AMCP dossiers, RWE plans, HTA readiness, cross-functional launch preparation, and build a high-performing outcomes and access team.
Summary Generated by Built In
Who we are:

Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years. For more information about our science, pipeline and people, please visit www.kymeratx.com or follow us on X (formerly Twitter) or LinkedIn. 


How we work:
  • PIONEER: We are courageous, resilient and rigorous in our mission to improve patients’ lives through our revolutionary degrader medicines.
  • COLLABORATE: We value trust + transparency from everyone. Our goals are shared, our decisions data-driven and our camaraderie genuine.
  • BELONG: We recognize our differences, inviting curiosity and inclusivity, so that our people are valued, seen, and heard.

How you’ll make an impact:

The Senior Director, Outcomes, Value & Access will serve as Kymera’s strategic leader for health economics, real-world evidence (RWE), value communication, and payer-relevant medical strategy across the pipeline. Reporting to the VP of Medical Affairs, this role will shape and execute the company’s integrated outcomes and access strategy to support optimized patient access, informed clinical decision-making, and successful product commercialization. The ideal candidate is an experienced HEOR leader with deep immunology expertise (dermatology and/or respiratory strongly preferred), a proven track record preparing for and supporting launches, and significant experience engaging national and regional payer stakeholders.

  • Strategic and forward-thinking, with the ability to translate scientific evidence into compelling value narratives.
  • Highly collaborative, diplomatic, and influential across functions and levels.
  • Strong communicator with exceptional scientific and business acumen.
  • Comfort working in a dynamic, rapidly growing biotech setting.

Strategic Leadership & Vision

  • Lead the development and execution of Kymera’s Medical Outcomes, Value & Access strategy across the immunology portfolio.
  • Serve as a core member of the Medical Affairs Team, advising on evidence generation, clinical strategy, and payer-relevant insights.
  • Drive cross-functional alignment on value strategy across Medical Affairs, HEOR, Market Access, Clinical Development, Regulatory, Commercial, and Global teams.

Health Economics & Outcomes Research (HEOR)

  • Oversee HEOR strategy, including economic modeling, treatment-pattern studies, and comparative-effectiveness analyses.
  • Guide development and validation of economic models (e.g., budget impact, cost-effectiveness) to support payer decision-making.
  • Lead creation of AMCP dossiers, value narratives, and scientific payer resources.

Real-World Evidence & Data Generation

  • Design and oversee RWE plans, including study concept refinement, protocol development, external data partnerships, and post-marketing evidence strategy.
  • Partner with Clinical Development and Data Science teams to integrate outcomes-focused endpoints into clinical trial design.

Payer & External Stakeholder Engagement

  • Build and maintain relationships with U.S. payer organizations, HTAs, integrated delivery networks, and employer groups to communicate clinical and economic value.
  • Lead scientific exchange with medical directors, formulary decision-makers, and population-health leaders.
  • Conduct advisory boards on HEOR, RWE, and access-related topics.

Cross-Functional Collaboration & Enablement

  • Provide leadership for value and access–related launch preparation.
  • Collaborate with Market Access to ensure scientific accuracy and strategic alignment of access resources.
  • Serve as lead on health technology assessment (HTA) readiness for future ex-US markets, in partnership with global teams.
  • Support field medical teams with training on HEOR, RWE, and payer communication.

Team Leadership & Development

  • Build and lead a high-performing Outcomes, Value & Access team, fostering a culture of scientific excellence, collaboration, and accountability.
  • Manage budgets, timelines, and resource allocation across projects and vendors.

Skills and experience you’ll bring:

Required

  • Advanced degree: PharmD, PhD, MD, MS/MPH in HEOR, Epidemiology, or related field.
  • 10+ years of experience in Medical Affairs, HEOR, Market Access, or related roles in the biopharmaceutical industry.
  • Demonstrated leadership in building or expanding HEOR or Medical Value/Access functions.
  • Strong therapeutic experience in immunology, with dermatology and/or respiratory as a plus.
  • Proven track record developing payer-focused HEOR strategy, RWE programs, value communication tools, and AMCP dossiers.
  • Experience engaging directly with national and regional payer decision-makers.
  • Strong understanding of U.S. healthcare economics, HTA landscapes, and evolving value-based frameworks.
  • Ability to work collaboratively in a fast-paced, science-driven, cross-functional environment.

Preferred

  • Experience supporting early-stage to launch-stage products in specialty immunology.
  • Prior leadership of field-based payer medical teams.
  • Global or ex-U.S. HEOR/HTA exposure.
  • Experience in small or mid-size biotech environments.

                                                                                                                                                                                


Equal Employment Opportunity

Kymera Therapeutics is proud to be an equal opportunity employer, seeking to create a welcoming and diverse environment.  All applicants will receive consideration for employment without regard to race, color, religion, creed, gender, national origin, age, disability, veteran status, pregnancy, sex, marital status, gender expression or identity, genetic information, sexual orientation, citizenship, or any other legally protected class.


Compensation

  • Kymera offers a competitive compensation package that recognizes both results and capabilities through market-based, performance-driven pay.
  • The anticipated base salary range for this role is $235,000 – $330,000, with eligibility for annual bonus, equity participation, and comprehensive benefits.
  • Actual salary is based on a holistic evaluation of the specific role/level as well as each candidate’s depth of experience and the capabilities they bring to the position.


Skills Required

  • Advanced degree (PharmD, PhD, MD, MS/MPH in HEOR, Epidemiology, or related field)
  • 10+ years experience in Medical Affairs, HEOR, Market Access, or related biopharmaceutical roles
  • Demonstrated leadership building or expanding HEOR or Medical Value/Access functions
  • Strong therapeutic experience in immunology (dermatology and/or respiratory a plus)
  • Proven track record developing payer-focused HEOR strategy, RWE programs, value communication tools, and AMCP dossiers
  • Experience engaging directly with national and regional payer decision-makers
  • Strong understanding of U.S. healthcare economics, HTA landscapes, and evolving value-based frameworks
  • Ability to work collaboratively in a fast-paced, science-driven, cross-functional environment
  • Experience supporting early-stage to launch-stage products in specialty immunology
  • Prior leadership of field-based payer medical teams
  • Global or ex-U.S. HEOR/HTA exposure
  • Experience in small or mid-size biotech environments

Kymera Therapeutics Compensation & Benefits Highlights

The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Kymera Therapeutics and has not been reviewed or approved by Kymera Therapeutics.

  • Fair & Transparent Compensation Pay is considered market‑competitive for core scientific and leadership roles, with clearly posted ranges visible for U.S. openings. Feedback suggests strong base pay aligns with comments about high salary and good pay.
  • Equity Value & Accessibility Employees are eligible to participate in broad‑based equity programs, including an equity incentive plan and an ESPP. Feedback suggests this ownership opportunity can meaningfully augment total compensation in a growth‑focused setting.
  • Leave & Time Off Breadth Company‑wide office shutdowns, standard PTO, and summer schedules are promoted to help people unplug. Feedback suggests these practices contribute to a well‑rounded time‑off offering.

Kymera Therapeutics Insights

Am I A Good Fit?
beta
Get Personalized Job Insights.
Our AI-powered fit analysis compares your resume with a job listing so you know if your skills & experience align.

The Company
HQ: Watertown, Massachusetts
208 Employees
Year Founded: 2016

What We Do

Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on delivering oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Kymera is also progressing degrader oncology programs that target undrugged or poorly drugged proteins to create new ways to fight cancer. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years

Similar Jobs

Cox Enterprises Logo Cox Enterprises

Sales Strategy & Enablement Director

Artificial Intelligence • Automotive • Greentech • Information Technology • Machine Learning • Software • Cybersecurity
Remote or Hybrid
United States
30000 Employees
135K-225K Annually

SharkNinja Logo SharkNinja

AI & Data Analytics Opportunities

Beauty • Robotics • Design • Appliances • Manufacturing
In-Office
Needham, MA, USA
4000 Employees
125K-195K Annually

SharkNinja Logo SharkNinja

Senior Consumer Insights Analyst - Beauty

Beauty • Robotics • Design • Appliances • Manufacturing
In-Office
Needham, MA, USA
4000 Employees
74K-110K Annually

SharkNinja Logo SharkNinja

Program Manager

Beauty • Robotics • Design • Appliances • Manufacturing
In-Office
Needham, MA, USA
4000 Employees
135K-170K Annually

Similar Companies Hiring

Sailor Health Thumbnail
Healthtech • Social Impact • Telehealth
New York City, NY
20 Employees
Granted Thumbnail
Artificial Intelligence • Healthtech • Insurance • Mobile • Financial Services
New York, New York
23 Employees
OneImaging Thumbnail
Healthtech
Miami, FL
62 Employees

Sign up now Access later

Create Free Account

Please log in or sign up to report this job.

Create Free Account